Healthcare and pharma companies like Amgen have two distinct categories of AI need: accelerating pure R&D work involving massive scientific datasets, and automating the heavy administrative and document-authoring burden required to get an approved drug to market.
Olivier Godement describes working with Amgen and explains that healthcare/pharma AI opportunities fall into two buckets: R&D acceleration and automating the massive admin and regulatory documentation workload.
transcript
Olivier Godement: I feel like they are two big buckets of needs. One is, like, pure R&D. It's like, you know, you're seeing, like, a massive amount of data and, like, you have super smart scientists who are trying to, you know, come by, test out things, you know. A second bucket is, like, you know, much more, like, you know, common across other industries. It's, like, pure, like, you know, admin, document authoring, document-scribing work.